Overview
- 16 inspections across 12 sites are on record.
- 41 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-04-22.
At a glance
Inspections
16
Sites
12
Observations
41
Career since
Mar 2024
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Accugenix LLC | 22 Apr 2026 | Human Drugs | |
| Newton Laboratories, Inc. | 26 Mar 2026 | Human Drugs | On file |
| KP Pharmaceutical Technology | 13 Feb 2026 | Human Drugs | |
| J.M. Murray Center, Inc. | 19 Sep 2025 | Human Drugs | On file |
| Janssen Pharmaceuticals, Inc | 14 Aug 2025 | Human Drugs |
Sites inspected
Accugenix LLCNewark, United States1 insp.
Newton Laboratories, Inc.Conyers, United States1 insp.
KP Pharmaceutical TechnologyBloomington, United States1 insp.
J.M. Murray Center, Inc.Cortland, United States1 insp.
Janssen Pharmaceuticals, IncTitusville, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Stephenie M Ortiz5 shared
JoshRenzo N Ramilo4 shared
Josh Renzo N Ramilo4 shared
Edmund F Mrak2 shared
Michelle Lin1 shared
Lisa R Hilliard1 shared
Martin M Kimani1 shared
Robert J Ham1 shared
Catherine O Lamptey1 shared
Pushpa S Jayasekara1 shared
Full investigator report
Get the verbatim findings behind John D Mcintosh's 41 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site